Total Payments
$6,192
2024 Payments
$807.58
Companies
38
Transactions
450
Medicare Patients
3,030
Medicare Billing
$221,315
Payment Breakdown by Category
Food & Beverage$6,182 (99.8%)
Education$10.52 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,182 | 449 | 99.8% |
| Education | $10.52 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,438 | 119 | $0 (2024) |
| ABBVIE INC. | $687.09 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $445.07 | 20 | $0 (2024) |
| Amgen Inc. | $424.00 | 27 | $0 (2024) |
| Lilly USA, LLC | $414.61 | 29 | $0 (2024) |
| PFIZER INC. | $406.27 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $349.60 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $190.76 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $188.66 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $182.51 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $807.58 | 43 | AstraZeneca Pharmaceuticals LP ($250.87) |
| 2023 | $733.13 | 51 | AbbVie Inc. ($221.18) |
| 2022 | $1,064 | 74 | Novo Nordisk Inc ($284.81) |
| 2021 | $987.40 | 69 | Novo Nordisk Inc ($228.04) |
| 2020 | $659.38 | 49 | Novo Nordisk Inc ($168.32) |
| 2019 | $647.54 | 51 | Novo Nordisk Inc ($176.42) |
| 2018 | $598.65 | 49 | Novo Nordisk Inc ($124.15) |
| 2017 | $694.68 | 64 | Novo Nordisk Inc ($174.76) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Insulin Pump | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $126.34 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.50 | General |
| 05/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Obesity | ||||||
| 05/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiology | ||||||
| 04/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Obesity | ||||||
| 04/10/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 375 | 948 | $115,729 | $40,908 |
| 2022 | 9 | 425 | 731 | $87,984 | $32,961 |
| 2021 | 18 | 990 | 1,772 | $177,583 | $78,314 |
| 2020 | 21 | 1,240 | 2,062 | $185,548 | $69,133 |
Total Patients
3,030
Total Services
5,513
Medicare Billing
$221,315
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 310 | $80,600 | $25,848 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 90 | $12,780 | $4,997 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $5,535 | $3,177 | 57.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $1,958 | $1,592 | 81.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 156 | $3,015 | $1,447 | 48.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,116 | $1,030 | 92.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,056 | $970.20 | 91.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 15 | 19 | $1,289 | $623.16 | 48.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,914 | $593.39 | 31.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 14 | 30 | $600.00 | $267.74 | 44.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 15 | $465.00 | $227.08 | 48.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 83 | $2,075 | $85.69 | 4.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 22 | 133 | $3,325 | $50.05 | 1.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 178 | $44,366 | $15,163 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 199 | $27,688 | $9,898 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $7,618 | $4,489 | 58.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,412 | $1,230 | 87.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 53 | 134 | $3,562 | $1,059 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 32 | $1,034 | $865.38 | 83.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 13 | 23 | $472.00 | $174.58 | 37.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 31 | 70 | $1,121 | $65.50 | 5.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 17 | 39 | $711.00 | $15.28 | 2.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 202 | 360 | $72,720 | $30,471 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 152 | 152 | $33,288 | $19,264 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 182 | $25,140 | $10,701 | 42.6% |
About Dr. Andrea Watson, MD
Dr. Andrea Watson, MD is a Family Medicine healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1801036934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Watson, MD has received a total of $6,192 in payments from pharmaceutical and medical device companies, with $807.58 received in 2024. These payments were reported across 450 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,182).
As a Medicare-enrolled provider, Watson has provided services to 3,030 Medicare beneficiaries, totaling 5,513 services with total Medicare billing of $221,315. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Elizabethtown, KY
- Active Since 03/02/2009
- Last Updated 05/25/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801036934
Products in Payments
- Saxenda (Drug) $431.06
- Ozempic (Drug) $391.60
- JARDIANCE (Drug) $309.79
- VRAYLAR (Drug) $304.14
- Aimovig (Biological) $233.53
- UBRELVY (Drug) $216.96
- QULIPTA (Drug) $203.26
- BREZTRI (Drug) $196.36
- Kerendia (Drug) $190.76
- FARXIGA (Drug) $183.75
- CHANTIX (Drug) $179.52
- TRELEGY ELLIPTA (Drug) $149.82
- Wegovy (Drug) $141.11
- Rybelsus (Drug) $122.17
- EMGALITY (Drug) $108.96
- TRULICITY (Drug) $95.66
- JANUVIA (Drug) $94.23
- NURTEC ODT (Drug) $89.93
- Victoza (Drug) $88.93
- XIFAXAN (Drug) $86.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Elizabethtown
Patrick Gilhool, Do, DO
Family Medicine — Payments: $12,298
Family Medicine $12,298
Dr. Jahin Patel, Md, MD
Family Medicine — Payments: $7,229
Family Medicine $7,229
Dr. Paul Gerard, M.d, M.D
Family Medicine — Payments: $6,185
Family Medicine $6,185
Christopher Brabazon, Do, DO
Family Medicine — Payments: $3,187
Family Medicine $3,187
Dr. Kelsey Pappas, Md, MD
Family Medicine — Payments: $3,170
Family Medicine $3,170
Gregory Smith, M.d, M.D
Family Medicine — Payments: $2,838
Family Medicine $2,838